ClinicalTrials.govpublic full text
Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
infections, papillomavirus, viral infections, human papillomavirus (hpv) vaccine, safety, vaccine, immunogenicity, cervical cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 852881
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.